18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates.

      Journal of Medical Microbiology
      Adhesins, Bacterial, genetics, Antigens, Bacterial, analysis, Diarrhea, microbiology, Escherichia coli, isolation & purification, Escherichia coli Infections, Escherichia coli Proteins, Genomic Islands, Hemolytic-Uremic Syndrome, Humans, London, Molecular Epidemiology, O Antigens, Prophages, Serotyping, Virulence Factors

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Enterohaemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli are important diarrhoeagenic pathogens; infection is dependent on translocation of a number of type III effector proteins. Until recently all the known effectors were encoded on the LEE pathogenicity island, which also encodes the adhesin intimin and the type III secretion apparatus. Recently, a novel non-LEE effector protein, EspI/NleA, which is required for full virulence in vivo and is encoded on a prophage, was identified. The aim of this study was to determine the distribution of espI among clinical EHEC and EPEC isolates. espI was detected in 86 % and 53 % of LEE+ EHEC and EPEC strains, respectively. Moreover, the espI gene was more commonly found in patients suffering from a more severe disease.

          Related collections

          Author and article information

          Comments

          Comment on this article